How to appeal an Elevance Health glp-1 weight-loss drugs denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Elevance Health-specific note: Operates Anthem BCBS in 14 states. Owns Carelon (formerly AIM) which manages utilization for specialty drugs and advanced imaging. State complaint route is to the state insurance department where the policy was issued.

What Elevance Health's policy requires for glp-1 weight-loss drugs

Cited policy: MP - Weight Loss Pharmacotherapy

BMI >=30, OR BMI >=27 with comorbidity. Comprehensive weight loss program participation. Continued benefit requires >=5% loss at 12 weeks.

How Elevance Health denies glp-1 weight-loss drugs — and how to counter it

Where Elevance Health pushes back: 1) BMI documentation outdated (>6 months); 2) No supervised weight loss program; 3) 12-week benefit review failed (<5% loss); 4) State-specific plans (TX, FL, AZ) more restrictive.

Counter-arguments that hold up: Request fresh BMI at appeal. Supervised program: include any structured program incl. virtual (Noom, WW digital). 12-week review failure: argue 24-week review citing STEP-1 mean loss at week 68 of 14.9%. State-specific: cite state insurance commissioner precedents.

What Elevance Health typically denies for glp-1 weight-loss drugs

Across Elevance Health's commercial and Medicare books, denials cluster around a small number of patterns. For glp-1 weight-loss drugs, expect:

• Step therapy
• Medical necessity for biologics
• Out-of-network for behavioral health
• Bariatric surgery prior auth

Treatments most often denied in this category

These are the glp-1 weight-loss drugs treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Wegovy
• Zepbound
• Mounjaro
• Ozempic
• Saxenda
• PHENTERMINE AND TOPIRAMATE

How to submit the appeal to Elevance Health

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Elevance Health cited in the denial.
3. File the appeal through Elevance Health's portal (members: https://www.anthem.com ; providers: https://providers.anthem.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In IN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Elevance Health's prior-authorization criteria by drug: Elevance Health PA criteria on ApprovalHelp.